Pomerantz To Lead Securities Suit Against WuXi

By Adam Lidgett (May 29, 2019, 2:32 PM EDT) -- Law firm Pomerantz will serve as lead counsel in a proposed class action accusing pharmaceutical research and development company WuXi of keeping investors in the dark about plans to spin off subsidiaries following a merger that took the company private, a New York federal judge has ruled....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!